Fresenius SE & Co. KGaA Stock price

Equities

FRE

DE0005785604

Healthcare Facilities & Services

Market Closed - Xetra 11:35:25 2024-03-01 am EST 5-day change 1st Jan Change
25.8 EUR -0.31% Intraday chart for Fresenius SE & Co. KGaA +0.51% -8.09%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Enjoy this offer
* See conditions on site
Sales 2023 22.3B 24.16B Sales 2024 * 23.04B 24.97B Capitalization 14.53B 15.75B
Net income 2023 * 655M 710M Net income 2024 * 1.46B 1.58B EV / Sales 2023 0.71 x
Net Debt 2023 * 18.03B 19.54B Net Debt 2024 * 16.67B 18.06B EV / Sales 2024 * 1.35 x
P/E ratio 2023 *
16.4 x
P/E ratio 2024 *
9.96 x
Employees 193,527
Yield 2023 *
2.67%
Yield 2024 *
3.64%
Free-Float 73.04%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Fresenius SE & Co. KGaA

1 day-0.31%
1 week+0.51%
Current month-0.31%
1 month+1.38%
3 months-11.31%
6 months-12.36%
Current year-8.09%
More quotes
1 week
25.48
Extreme 25.48
26.36
1 month
25.13
Extreme 25.13
27.27
Current year
25.13
Extreme 25.13
29.20
1 year
23.29
Extreme 23.29
31.22
3 years
19.69
Extreme 19.69
47.60
5 years
19.69
Extreme 19.69
52.82
10 years
19.69
Extreme 19.69
80.07
More quotes
Managers TitleAgeSince
Chief Executive Officer 55 21-04-11
Director of Finance/CFO 44 18-12-31
Public Communications Contact - -
Members of the board TitleAgeSince
Director/Board Member 69 15-05-19
Chairman 69 19-12-31
Director/Board Member 63 16-05-12
More insiders
Date Price Change Volume
24-03-01 25.8 -0.31% 936,649
24-02-29 25.88 -0.42% 2,143,576
24-02-28 25.99 -0.35% 745,562
24-02-27 26.08 +0.50% 963,868
24-02-26 25.95 +1.09% 1,058,471

Delayed Quote Xetra, March 01, 2024 at 11:35 am EST

More quotes
Fresenius SE & Co. KGaA specializes in designing, producing, and selling medical drugs, equipment, and devices used in clinical hospitalization and at home. Net sales break down by activity as follows: - dialysis treatment (46.9%; Fresenius Medical Care): sales of equipment for hemodialysis, pediatric dialysis, peritoneal dialysis, dialysis services, etc.; - hospital administration and engineering (34.1%; Fresenius Vamed and Fresenius Helios): management of technical facilities and medical equipment, hospital management, design and production of medical equipment for the pharmaceutical sector, etc.; - perfusion and clinical nutrition (19%; Fresenius Kabi): sales of parenteral and oral nutrition products, perfusion and vascular filling equipment, transfusion materials, generic injectable products, home medical assistance services in the areas of perfusion, nutrition, and oxygen therapy, etc. Net sales are distributed geographically as follows: Europe (43.8%), North America (39.4%), Asia/Pacific (10.1%), Latin America (5.4%) and Africa (1.3%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
25.8 EUR
Average target price
38.21 EUR
Spread / Average Target
+48.08%
Consensus
  1. Stock
  2. Equities
  3. Stock Fresenius SE & Co. KGaA - Xetra
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities.
SIGN UP NOW